Larvol Delta - RedHill-Biopharma-Ltdannounced-that-the-US-Food-and-Drug-Administration-FDA-has-granted-rare-pediatric-disease-RPD-designation-to-opaganib-for-treatment-of-neuroblastoma-NB

Yeliva (opaganib) - RedHill

https://www.prnewswire.com/news-releases/redhills-opaganib-receives-fda-rare-pediatric-disease-designation-for-neuroblastoma-in-addition-to-current-orphan-drug-designation-302795146.html

Jun 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next